Viatris Inc. (VIA)
Munich
Closed
Aug 25, 2026
Day's Range
14.0752 wk Range
8.12Overview - VIA - Viatris Inc.
Key Statistics
Valuation
Enterprise Value
27.81B
P/E (Trailing)
‪27.27‬
Price / Sales (TTM)
‪1.01‬
Price / Book
‪1.16‬
EV / EBITDA
‪11.03‬
Profitability
Gross Margin
‪38.76%‬
Profit Margin
‪35.05%‬
Operating Margin
‪-22.33%‬
Return on Assets
‪-9.45%‬
Return on Equity
‪-23.89%‬
Ownership
Shares Outstanding
1.15B
Price stats
50-Day Avg
‪14.47‬
200-Day Avg
‪12.49‬
Dividends
Frequency
Quarterly
Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - VIA - Viatris Inc.
Peers - VIA - Viatris Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on Munich.
Profile Summary - VIA - Viatris Inc.
About
Viatris Inc. is a global healthcare company that delivers quality medicines and innovative solutions to improve health access worldwide. It offers a dynamic portfolio spanning generics, including commoditized, complex products and biosimilars, alongside globally recognized established brands such as Lipitor, Norvasc,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
